Form 4: Femasys Executive Receives Stock Grant
Insider Transaction (Form 4)
Jeffrey Gerald Mifek, Chief Clinical-Medical Affairs of Femasys Inc, received 6,250 shares of common stock on July 6, 2026.
Summary
- Grant/award: acquired 6,250 Stock Option (Right to Buy) on July 6, 2026; holds 6,250 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Jeffrey Gerald Mifek — Officer (Chief Clinical-Medical Affairs)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-06 | Grant/award | Stock Option (Right to Buy) | 6,250 | — | — | 6,250 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-06 | Grant/award (6,250 shares) |
Keywords
insider transaction, Form 4, FEMY, FEMASYS INC, neutral, Jeffrey Gerald Mifek
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.